335 related articles for article (PubMed ID: 28301816)
21. Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors.
Tzvetkov NT; Stammler HG; Neumann B; Hristova S; Antonov L; Gastreich M
Eur J Med Chem; 2017 Feb; 127():470-492. PubMed ID: 28107736
[TBL] [Abstract][Full Text] [Related]
22. Identification of Indole-Based Chalcones: Discovery of a Potent, Selective, and Reversible Class of MAO-B Inhibitors.
Sasidharan R; Manju SL; Uçar G; Baysal I; Mathew B
Arch Pharm (Weinheim); 2016 Aug; 349(8):627-37. PubMed ID: 27373997
[TBL] [Abstract][Full Text] [Related]
23. 4-tert-Pentylphenoxyalkyl derivatives - Histamine H
Łażewska D; Olejarz-Maciej A; Kaleta M; Bajda M; Siwek A; Karcz T; Doroz-Płonka A; Cichoń U; Kuder K; Kieć-Kononowicz K
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3596-3600. PubMed ID: 30404719
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in the development of selective human MAO-B inhibitors: (hetero)arylidene-(4-substituted-thiazol-2-yl)hydrazines.
Secci D; Bolasco A; Carradori S; D'Ascenzio M; Nescatelli R; Yáñez M
Eur J Med Chem; 2012 Dec; 58():405-17. PubMed ID: 23153812
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's disease.
Joubert J; Foka GB; Repsold BP; Oliver DW; Kapp E; Malan SF
Eur J Med Chem; 2017 Jan; 125():853-864. PubMed ID: 27744252
[TBL] [Abstract][Full Text] [Related]
27. New 2H-chromene-3-carboxamide derivatives: design, synthesis and use as inhibitors of hMAO.
Pan ZX; He X; Chen YY; Tang WJ; Shi JB; Tang YL; Song BA; Li J; Liu XH
Eur J Med Chem; 2014 Jun; 80():278-84. PubMed ID: 24793878
[TBL] [Abstract][Full Text] [Related]
28. New coumarin derivatives: design, synthesis and use as inhibitors of hMAO.
He X; Chen YY; Shi JB; Tang WJ; Pan ZX; Dong ZQ; Song BA; Li J; Liu XH
Bioorg Med Chem; 2014 Jul; 22(14):3732-8. PubMed ID: 24856304
[TBL] [Abstract][Full Text] [Related]
29. Potent and selective MAO-B inhibitory activity: amino- versus nitro-3-arylcoumarin derivatives.
Matos MJ; Rodríguez-Enríquez F; Vilar S; Santana L; Uriarte E; Hripcsak G; Estrada M; Rodríguez-Franco MI; Viña D
Bioorg Med Chem Lett; 2015 Feb; 25(3):642-8. PubMed ID: 25532905
[TBL] [Abstract][Full Text] [Related]
30. Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson's disease: Synthesis, biochemistry, and molecular dynamics study.
Thomas Parambi DG; Oh JM; Kumar S; Sudevan ST; Hendawy OM; Abdelgawad MA; Musa A; Al-Sanea MM; Ahmad I; Patel H; Kim H; Mathew B
Comput Biol Chem; 2023 Aug; 105():107899. PubMed ID: 37315342
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, Biological Evaluation and Molecular Modeling Studies of Propargyl-Containing 2,4,6-Trisubstituted Pyrimidine Derivatives as Potential Anti-Parkinson Agents.
Kumar B; Kumar M; Dwivedi AR; Kumar V
ChemMedChem; 2018 Apr; 13(7):705-712. PubMed ID: 29534334
[TBL] [Abstract][Full Text] [Related]
32. Design, Synthesis and hMAO Inhibitory Screening of Novel 2-Pyrazoline Analogues.
Evranos-Aksoz B; Ucar G; Yelekci K
Comb Chem High Throughput Screen; 2017; 20(6):510-521. PubMed ID: 28474546
[TBL] [Abstract][Full Text] [Related]
33. Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study.
Matos MJ; Vilar S; Gonzalez-Franco RM; Uriarte E; Santana L; Friedman C; Tatonetti NP; Viña D; Fontenla JA
Eur J Med Chem; 2013 May; 63():151-61. PubMed ID: 23474901
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of new hydrazone derivatives and evaluation of their monoamine oxidase inhibitory activity.
Tok F; Sağlık BN; Özkay Y; Ilgın S; Kaplancıklı ZA; Koçyiğit-Kaymakçıoğlu B
Bioorg Chem; 2021 Sep; 114():105038. PubMed ID: 34102520
[TBL] [Abstract][Full Text] [Related]
35. Synthesis,
Sağlık BN; Osmaniye D; Acar Çevik U; Levent S; Kaya Çavuşoğlu B; Atlı Eklioğlu Ö; Özkay Y; Koparal AS; Kaplancıklı ZA
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1422-1432. PubMed ID: 32602377
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, in vitro, and in silico studies of new derivatives of diphenylpiperazine scaffold: A key substructure for MAO inhibition.
El-Halaby LO; El-Husseiny WM; El-Messery SM; Goda FE
Bioorg Chem; 2024 Feb; 143():107011. PubMed ID: 38061181
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, Biochemistry, and Computational Studies of Brominated Thienyl Chalcones: A New Class of Reversible MAO-B Inhibitors.
Mathew B; Haridas A; Uçar G; Baysal I; Joy M; Mathew GE; Lakshmanan B; Jayaprakash V
ChemMedChem; 2016 Jun; 11(11):1161-71. PubMed ID: 27159243
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase B inhibitors.
Matos MJ; Terán C; Pérez-Castillo Y; Uriarte E; Santana L; Viña D
J Med Chem; 2011 Oct; 54(20):7127-37. PubMed ID: 21923181
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, in vitro, and in silico studies of 1,2,4-triazole-piperazine hybrid derivatives as potential MAO inhibitors.
Uslu H; Osmaniye D; Sağlik BN; Levent S; Özkay Y; Benkli K; Kaplancikli ZA
Bioorg Chem; 2021 Dec; 117():105430. PubMed ID: 34678603
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, in vitro and in silico evaluation of new pyrrole derivatives as monoamine oxidase inhibitors.
Altintop MD; Sever B; Osmaniye D; Sağlık BN; Özdemir A
Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800082. PubMed ID: 29963739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
